North America Oligonucleotide Synthesis Market

The North America Oligonucleotide Synthesis Market size was valued at US$ 609.90 Mn in 2018 and is projected to reach US$ $ 1,541.03 Mn by 2027, growing at a CAGR of 11.2% during 2019 - 2027.

Report Coverage
  • Product: Synthesized Oligonucleotides, Reagents, Equipment
  • Application: Research, Diagnostics, Therapeutics
  • End User: Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Other End Users
US$ 609.90 Mn Market size in 2018
US$ $ 1,541.03 Mn Market Size by 2027
11.2% CAGR, 2019 - 2027
2019-2027 Forecast Period

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. North America Oligonucleotide Synthesis Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. North America Oligonucleotide Synthesis Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. North America Oligonucleotide Synthesis Market Regional Analysis

6.2 North America Oligonucleotide Synthesis Market Revenue 2016-2027 (US$ Million)
6.3 North America Oligonucleotide Synthesis Market Forecast Analysis

7. North America Oligonucleotide Synthesis Market Analysis – by Product

7.1 Synthesized Oligonucleotides
  • 7.1.1 Overview
  • 7.1.2 Synthesized Oligonucleotides: North America Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)
7.2 Reagents
  • 7.2.1 Overview
  • 7.2.2 Reagents: North America Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)
7.3 Equipment
  • 7.3.1 Overview
  • 7.3.2 Equipment: North America Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)

8. North America Oligonucleotide Synthesis Market Analysis – by Application

8.1 Research
  • 8.1.1 Overview
  • 8.1.2 Research: North America Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)
8.2 Diagnostics
  • 8.2.1 Overview
  • 8.2.2 Diagnostics: North America Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)
8.3 Therapeutics
  • 8.3.1 Overview
  • 8.3.2 Therapeutics: North America Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)

9. North America Oligonucleotide Synthesis Market Analysis – by End User

9.1 Academic Research Institutes
  • 9.1.1 Overview
  • 9.1.2 Academic Research Institutes: North America Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)
9.2 Pharmaceutical & Biotechnology Companies
  • 9.2.1 Overview
  • 9.2.2 Pharmaceutical & Biotechnology Companies: North America Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)
9.3 Diagnostic Laboratories
  • 9.3.1 Overview
  • 9.3.2 Diagnostic Laboratories: North America Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)
9.4 Other End Users
  • 9.4.1 Overview
  • 9.4.2 Other End Users : North America Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)

10. North America Oligonucleotide Synthesis Market – North America Analysis

10.1 Overview

10.2 North America
  • 10.2.1 North America Oligonucleotide Synthesis Market Breakdown, by Key Country, 2019 and 2027 (%)
  • 10.2.1.1 North America Oligonucleotide Synthesis Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 US: North America Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.1.1 US: North America Oligonucleotide Synthesis Market Breakdown, by Product
    • 10.2.1.1.2 US: North America Oligonucleotide Synthesis Market Breakdown, by Application
    • 10.2.1.1.3 US: North America Oligonucleotide Synthesis Market Breakdown, by End User
  • 10.2.1.2 Canada: North America Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.2.1 Canada: North America Oligonucleotide Synthesis Market Breakdown, by Product
    • 10.2.1.2.2 Canada: North America Oligonucleotide Synthesis Market Breakdown, by Application
    • 10.2.1.2.3 Canada: North America Oligonucleotide Synthesis Market Breakdown, by End User
  • 10.2.1.3 Mexico : North America Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.3.1 Mexico : North America Oligonucleotide Synthesis Market Breakdown, by Product
    • 10.2.1.3.2 Mexico : North America Oligonucleotide Synthesis Market Breakdown, by Application
    • 10.2.1.3.3 Mexico : North America Oligonucleotide Synthesis Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Thermo Fisher Scientific Inc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 GenScript
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Molecular Assemblies
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Twist Biosciences
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Evonetix
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 DNA Script
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Nuclera Nucleics
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Camena Bioscience
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Synthomics
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Ansa Biotechnologies
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

Access the Full N Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Access the full N Market Report
134 pages PDF & Excel | 2019-11-04